For 30 years, Dr. Gregory E. Amidon has volunteered his time and expertise to USP, reflecting his commitment to the value of public standards as a way of ensuring the quality of products for people in the US and around the world. He brings extensive industrial, academic and volunteer experience and a deep understanding of the regulatory environment to his role as a Pharmaceutical Sciences Trustee for the 2020-2025 cycle. A USP volunteer since 1990, he has chaired several USP Expert Committees and Expert Panels, has served on the Council of Experts, and chaired the Board of Trustees Operations Committee during the 2015-2020 cycle.
Dr. Amidon has held numerous leadership roles in commercial, academic and non-profit organizations. He currently serves as Research Professor of Pharmaceutical Sciences at the University of Michigan, College of Pharmacy. This position affords him the ability to explore important new areas of research and the opportunity to educate the next generation of scientists. His transition to academia followed a distinguished career in pharmaceutical research and development for Pfizer, Pharmacia, Pharmacia & Upjohn, and The Upjohn Company. He is recognized for his expertise in the physical, chemical, and mechanical property characterization of active pharmaceutical ingredients, excipients, and products, as well as the development of scientific strategies for oral solid dosage form development. Being part of teams that brought new therapeutics to market are among the most rewarding parts of his career.
Dr. Amidon was elected Fellow of the American Association of Pharmaceutical Scientists (AAPS) and went on to serve as its president. His contributions and commitment to pharmaceutical quality have been recognized through several awards including the 2014 AAPS Research Achievement Award in Physical Pharmacy and Biopharmaceutics, the 2015 Champion of Quality Award from USP, and the Ebert Prize from the American Pharmaceutical Association.